| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $179.3M | +53.4% |
| Cost of Revenue | $18.6M | +162.3% |
| R&D Expense | $23.4M | -4.7% |
| SG&A Expense | $113.1M | +6.9% |
| Operating Income | $24.2M | +218.1% |
| Interest Expense | $7.9M | +15.2% |
| Pre-tax Income | $18.4M | +173.2% |
| Income Tax | $881K | — |
| Net Income | $17.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.7M | +73.1% |
| Short-term Investments | $20.6M | -14.8% |
| Accounts Receivable | $41.6M | +36.2% |
| Inventory | $6.0M | +8.7% |
| Current Assets | $135.1M | +36.1% |
| Total Assets | $164.0M | +39.9% |
| Current Liabilities | $63.3M | +18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.5M | +648.0% |
| Investing Cash Flow | $4.1M | +196.1% |
| Financing Cash Flow | -$11.6M | -163.4% |
| +169.7% |
| EPS (Basic) | $0.99 | +807.1% |
| EPS (Diluted) | $0.99 | +807.1% |
| Long-term Debt |
| $60.0M |
| +0.0% |
| Total Liabilities | $160.7M | +10.2% |
| Stockholders' Equity | $3.3M | +111.5% |